title: [Treatment of congenital insufficiency in fibrin stabilising factor (FSF or factor XIII) by purified factor XIII of placental origin. Report of two cases with a four year follow up].
authors.forename: B
authors.initials: B
authors.lastname: Caille
authors.forename: D
authors.initials: D
authors.lastname: Vergoz
authors.forename: J C
authors.initials: JC
authors.lastname: Vie
authors.forename: J P
authors.initials: JP
authors.lastname: Braive
authors.forename: F
authors.initials: F
authors.lastname: Capron
authors.forename: S
authors.initials: S
authors.lastname: Duriez
authors.forename: C
authors.initials: C
authors.lastname: Sarrade-Loucheur
authors.forename: F
authors.initials: F
authors.lastname: Ferrer
mesh_terms: D002648:Child; D002675:Child, Preschool; D002869:Chromosome Aberrations; D005176:Factor XIII / Q000627:therapeutic use*; D005177:Factor XIII Deficiency / Q000188:drug therapy* / Q000235:genetics; D005500:Follow-Up Studies; D005612:Freeze Drying; D005808:Genes, Recessive; D006470:Hemorrhage / Q000188:drug therapy / Q000235:genetics; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D008134:Long-Term Care; D008297:Male; D010375:Pedigree; D010924:Placental Extracts / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D010924:Placental Extracts; D005176:Factor XIII